Studies on adolescents and young adults with acute lymphoblastic leukemia suggest better results when using pediatric protocols for adult patients, while corresponding data for acute myeloid leukemia (AML) are limited
Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML) remains a ...
Acute lymphoblastic leukemia (ALL), a common child malignancy, also constitutes a minor fraction of ...
Adolescents and young adults (AYAs, 15-39 years) with acute lymphoblastic leukemia (ALL) represent a...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
BACKGROUND: While several studies have examined the treatment of adolescents and young adults (AYAs)...
In many areas of medicine adolescents are regarded as a discrete group with specific therapeutic, ps...
The objectives of this review were to discuss standard and investigational treatment strategies for ...
Abstract: The objectives of this review were to discuss standard and investigational treatment strat...
The primary objective of this review was to update and discuss the current concepts andthe results o...
Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML)remains a l...
Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML)remains a l...
Background: The objective was to compare 5-year overall survival (OS) between adolescent and young a...
BackgroundLittle is known about outcomes of acute myeloid leukemia (AML) in adolescents and young ad...
BackgroundStudies have demonstrated superior outcomes for adolescent and young adult (AYA) patients ...
Background Retrospective studies have shown adolescents and young adults (AYA) with acute lymphoblas...
Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML) remains a ...
Acute lymphoblastic leukemia (ALL), a common child malignancy, also constitutes a minor fraction of ...
Adolescents and young adults (AYAs, 15-39 years) with acute lymphoblastic leukemia (ALL) represent a...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
BACKGROUND: While several studies have examined the treatment of adolescents and young adults (AYAs)...
In many areas of medicine adolescents are regarded as a discrete group with specific therapeutic, ps...
The objectives of this review were to discuss standard and investigational treatment strategies for ...
Abstract: The objectives of this review were to discuss standard and investigational treatment strat...
The primary objective of this review was to update and discuss the current concepts andthe results o...
Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML)remains a l...
Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML)remains a l...
Background: The objective was to compare 5-year overall survival (OS) between adolescent and young a...
BackgroundLittle is known about outcomes of acute myeloid leukemia (AML) in adolescents and young ad...
BackgroundStudies have demonstrated superior outcomes for adolescent and young adult (AYA) patients ...
Background Retrospective studies have shown adolescents and young adults (AYA) with acute lymphoblas...
Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML) remains a ...
Acute lymphoblastic leukemia (ALL), a common child malignancy, also constitutes a minor fraction of ...
Adolescents and young adults (AYAs, 15-39 years) with acute lymphoblastic leukemia (ALL) represent a...